40 related articles for article (PubMed ID: 26329976)
1. Development and preliminary testing of a translational model of hepatocellular carcinoma for MR imaging and interventional oncologic investigations.
Thompson SM; Callstrom MR; Knudsen B; Anderson JL; Carter RE; Grande JP; Roberts LR; Woodrum DA
J Vasc Interv Radiol; 2012 Mar; 23(3):385-95. PubMed ID: 22265247
[TBL] [Abstract][Full Text] [Related]
2. Quantitative BOLD imaging at 3T: Temporal changes in hepatocellular carcinoma and fibrosis following oxygen challenge.
Patterson AJ; Priest AN; Bowden DJ; Wallace TE; Patterson I; Graves MJ; Lomas DJ
J Magn Reson Imaging; 2016 Sep; 44(3):739-44. PubMed ID: 26892734
[TBL] [Abstract][Full Text] [Related]
3. Non-Contrast Abbreviated Magnetic Resonance Imaging: A Cost-Effective Rookie in Hepatocellular Carcinoma Surveillance for Cirrhotic Patients.
Heo S; Choi WM
Gut Liver; 2024 Jan; 18(1):7-9. PubMed ID: 38221817
[No Abstract] [Full Text] [Related]
4. Differentiation between small hepatocellular carcinoma (<3 cm) and benign hepatocellular lesions in patients with Budd-Chiari syndrome: the role of multiparametric MR imaging.
Zandieh G; Shahbazian H; Tang H; Wu Q; Shaghaghi M; Hazhirkarzar B; Baghdadi A; Afyouni S; Verde F; Pawlik T; Kamel I
Front Oncol; 2023; 13():1282181. PubMed ID: 38074677
[TBL] [Abstract][Full Text] [Related]
5. Impact of Liver Fibrosis Severity on Oncological Prognosis in Hepatocellular Carcinoma.
Yasukawa K; Shimizu A; Kubota K; Notake T; Hosoda K; Hayashi H; Soejima Y
Liver Cancer; 2024 Apr; 13(2):150-160. PubMed ID: 38751553
[TBL] [Abstract][Full Text] [Related]
6. Regression of Hepatic Fibrosis and Evolution of Cirrhosis: A Concise Review.
Khan S; Saxena R
Adv Anat Pathol; 2021 Nov; 28(6):408-414. PubMed ID: 34326286
[TBL] [Abstract][Full Text] [Related]
7. Based on Gadolinium Ethoxybenzyl DTPA-Enhanced MRI: Diagnostic Performance of the Category-Modified LR-5 Criteria in Patients At Risk for Hepatocellular Carcinoma.
Li S; Deng K; Qiu J; Wang P; Yin D; Xie Y; Yu Y
Technol Cancer Res Treat; 2024; 23():15330338241256859. PubMed ID: 38780516
[No Abstract] [Full Text] [Related]
8. Hepatocellular Carcinoma in Non-Fibrotic Liver: A Narrative Review.
Naganuma H; Ishida H
Diagnostics (Basel); 2023 Nov; 13(22):. PubMed ID: 37998562
[TBL] [Abstract][Full Text] [Related]
9. Comparison of values of CT and MRI imaging in the diagnosis of hepatocellular carcinoma and analysis of prognostic factors.
Wang G; Zhu S; Li X
Oncol Lett; 2019 Jan; 17(1):1184-1188. PubMed ID: 30655882
[TBL] [Abstract][Full Text] [Related]
10. Diffusion-Weighted Imaging with Two Different b-Values in Detection of Solid Focal Liver Lesions.
Yang DW; Wang KY; Yao X; Ye HY; Jiang T; Liu Y; Gao JY; Chen M; Zhou C; Yang ZH
Biomed Res Int; 2016; 2016():8128207. PubMed ID: 27019851
[TBL] [Abstract][Full Text] [Related]
11. Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver.
Holland AE; Hecht EM; Hahn WY; Kim DC; Babb JS; Lee VS; West AB; Krinsky GA
Radiology; 2005 Dec; 237(3):938-44. PubMed ID: 16306035
[TBL] [Abstract][Full Text] [Related]
12. Arterial enhancing-only nodules less than 2 cm in diameter in patients with liver cirrhosis: predictors of hepatocellular carcinoma diagnosis on gadobenate dimeglumine-enhanced MR imaging.
Quaia E; Pizzolato R; De Paoli L; Angileri R; Ukmar M; Cova MA
J Magn Reson Imaging; 2013 Apr; 37(4):892-902. PubMed ID: 23097278
[TBL] [Abstract][Full Text] [Related]
13. An overview of hepatocellular carcinoma with atypical enhancement pattern: spectrum of magnetic resonance imaging findings with pathologic correlation.
Kovac JD; Ivanovic A; Milovanovic T; Micev M; Alessandrino F; Gore RM
Radiol Oncol; 2021 Jan; 55(2):130-143. PubMed ID: 33544992
[TBL] [Abstract][Full Text] [Related]
14. MR imaging of hepatocellular carcinoma.
Onaya H; Itai Y
Magn Reson Imaging Clin N Am; 2000 Nov; 8(4):757-68. PubMed ID: 11149678
[TBL] [Abstract][Full Text] [Related]
15. MR features of small hepatocellular carcinoma in normal, fibrotic, and cirrhotic livers: a comparative study.
Sheng RF; Zeng MS; Ji Y; Yang L; Chen CZ; Rao SX
Abdom Imaging; 2015 Oct; 40(8):3062-9. PubMed ID: 26329976
[TBL] [Abstract][Full Text] [Related]
16. MR comparative study of combined hepatocellular-cholangiocarcinoma in normal, fibrotic, and cirrhotic livers.
Sheng RF; Xie YH; Ji Y; Chen CZ; Yang L; Jin KP; Zeng MS
Abdom Radiol (NY); 2016 Nov; 41(11):2102-2114. PubMed ID: 27315077
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
